AIMCA
ACAD icon

Alberta Investment Management Corp (AIMCo)’s Acadia Pharmaceuticals ACAD Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-163,750
Closed -$5.84M – 494
2015
Q4 		$5.84M Buy
+163,750
New +$5.77M 0.07% 315
2014
Q3 		– Sell
-516,896
Closed -$11.7M – 480
2014
Q2 		$11.7M Hold
516,896
– – 0.13% 243
2014
Q1 		$12.6M Sell
516,896
-75,110
-13% -$1.9M 0.15% 210
2013
Q4 		$14.8M Buy
592,006
+146,400
+33% +$3.45M 0.19% 167
2013
Q3 		$12.2M Buy
+445,606
New +$9.32M 0.16% 211

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return